Patent ID: 7638625

Claim:
A crystalline form of 1-[4-amino-3,5-dibromo-N-[[4-(2,3,4,5-tetrahydro-2(1H)-oxo-1,3-benzodiazepin-3-yl)-1-piperidinyl]carbonyl]-D-phenylalanyl]-4-(1-piperidinyl)-piperidine-p-toluenesulphonate which, when subjected to X-ray powder diffraction, exhibits a characteristic diffraction pattern which yields the following calculated values for d (the interplanar spacing between the atoms in the crystal): 19.49 Å, 12.16 Å, 6.46 Å, 6.08 Å, 5.4 Å, 5.17 Å and 3.82 Å.